ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 219,14
0,38%
Dow Jones
39 512,84
0,32%
DAX
18 772,85
0,50%
Brent Oil
82,585
0,00%
Bitcoin
60 886,52
0,14%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Dyne Therapeutics Inc (DYN)

  7. Dyne Therapeutics Inc (DYN) Actualités

DYN Dyne Therapeutics Inc

26,00
0,05 (0,19%)
11 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Dyne Therapeutics Inc DYN NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,05 0,19% 26,00 06:00:08
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
25,96 25,07 26,48 26,00 25,95
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
02/5/202422:10GLOBEDyne Therapeutics Reports First Quarter 2024 Financial..
27/3/202421:05GLOBEDyne Therapeutics Reports Inducement Grant Under Nasdaq..
27/3/202413:30GLOBEDyne Therapeutics to Present at the Cantor Virtual Muscular..
25/3/202412:30GLOBEDyne Therapeutics Announces CEO Transition
13/3/202412:30GLOBEDyne Therapeutics to Present at Stifel 2024 Virtual CNS Days
11/3/202422:36EDGAR2Form 144 - Report of proposed sale of securities
11/3/202422:35EDGAR2Form 144 - Report of proposed sale of securities
11/3/202422:35EDGAR2Form 144 - Report of proposed sale of securities
08/3/202422:53EDGAR2Form 144 - Report of proposed sale of securities
08/3/202402:19EDGAR2Form 144 - Report of proposed sale of securities
08/3/202402:18EDGAR2Form 144 - Report of proposed sale of securities
08/3/202402:16EDGAR2Form 144 - Report of proposed sale of securities
05/3/202414:22EDGAR2Form S-3ASR - Automatic shelf registration statement of..
05/3/202413:41EDGAR2Form 8-K - Current report
05/3/202413:40EDGAR2Form S-8 - Securities to be offered to employees in employee..
05/3/202413:35EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
05/3/202413:30GLOBEDyne Therapeutics Reports Fourth Quarter and Full Year 2023..
02/3/202403:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202403:33EDGAR2Form 144 - Report of proposed sale of securities
01/3/202423:08EDGAR2Form 144 - Report of proposed sale of securities
01/3/202401:49EDGAR2Form 144 - Report of proposed sale of securities
23/2/202423:23EDGAR2Form 144 - Report of proposed sale of securities
14/2/202422:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202422:15GLOBEDyne Therapeutics Announces Upcoming Presentations on..
14/2/202414:39EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202423:40EDGAR2Form 144 - Report of proposed sale of securities
01/2/202413:30GLOBEDyne Therapeutics to Present at February Investor..
27/1/202401:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/1/202401:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/1/202401:46EDGAR2Form 144 - Report of proposed sale of securities
11/1/202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/1/202422:05GLOBEDyne Therapeutics Announces Closing of Public Offering of..
05/1/202422:07EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
05/1/202414:02EDGAR2Form 8-K - Current report
05/1/202413:30GLOBEDyne Therapeutics to Present at 42nd Annual J.P. Morgan..
05/1/202404:46GLOBEDyne Therapeutics Announces Pricing of $300 Million Public..
05/1/202403:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202403:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202403:45EDGAR2Form 144 - Report of proposed sale of securities
05/1/202403:45EDGAR2Form 144 - Report of proposed sale of securities
05/1/202403:19EDGAR2Form S-3MEF - Registration adding securities to prior Form..
04/1/202423:12EDGAR2Form 8-K - Current report
04/1/202402:14EDGAR2Form 144 - Report of proposed sale of securities
04/1/202402:12EDGAR2Form 144 - Report of proposed sale of securities
03/1/202422:37EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
03/1/202422:25GLOBEDyne Therapeutics Announces Proposed Public Offering of..
03/1/202412:37EDGAR2Form 8-K - Current report
03/1/202412:30GLOBEDyne Therapeutics Announces Positive Initial Clinical Data..
02/1/202422:05GLOBEDyne Therapeutics to Host Virtual Event Tomorrow, January 3..
30/12/202303:03EDGAR2Form 144 - Report of proposed sale of securities

Dernières Valeurs Consultées

NASDAQ
DYN
Dyne Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés